Table 2.
Number of prevalent HPV infections at different sites.
| (a) LG patients (n = 44) | No. of HPV types | |||
|---|---|---|---|---|
| Total | 0 (%) | 1 (%) | ≥ 2 (%) | |
| Cervical | 44 | 1 (2.3) | 11 (25) | 32 (72.7) |
| Anal# | 41 | 0 (0) | 8 (19.5) | 33 (80.5) |
| Oro-pharyngeal | 44 | 2 (4.5) | 13 (29.5) | 29 (65.9) |
| (b) HG patients (n = 56) | No. of HPV types | |||
| Total | 0 (%) | 1 (%) | ≥ 2 (%) | |
| Cervical | 56 | 3 (5.4) | 8 (14.3) | 45 (80.4) |
| Anal# | 52 | 9 (17.3) | 9 (17.3) | 34 (65.4) |
| Oro-pharyngeal | 56 | 6 (10.7) | 16 (28.6) | 34 (60.7) |
#missing/beta-globin negative samples were excluded from the analysis;
these differences in sampling availability were not significant
(Fisher's exact test, 2-tailed p = 0.2414 (a) and p = 0.1183 (b)).